http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102276401-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102276401-B1 |
| titleOfInvention | Composition for prevention or treatment of batten disease comprising scolopendrasin ii as an active ingredient |
| abstract | The present invention relates to a composition for preventing or treating Batten's disease containing scholopendracin II as an active ingredient. According to the present invention, scholopendracin II can be applied as a material for preventing or treating Batten's disease due to its excellent effect of reducing apoptosis and/or normalizing damaged mitochondrial function. |
| priorityDate | 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.